101 related articles for article (PubMed ID: 18837423)
1. Does 18F-fluorodeoxyglucose PET/CT have a role in the management of pulmonary and extra pulmonary sarcoidosis?
Carbone R; Douroukas A; Arena V; Cantalupi D; Balleari E; Ghio R; Pelosi E
Monaldi Arch Chest Dis; 2008 Jun; 69(2):81-2. PubMed ID: 18837423
[No Abstract] [Full Text] [Related]
2. [Application of fluorine-18 fluorodeoxyglucose-positron emission tomography in the diagnosis and therapy of patients with sarcoidosis].
Li D; Lü PX
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):447-50. PubMed ID: 24103209
[No Abstract] [Full Text] [Related]
3. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
[TBL] [Abstract][Full Text] [Related]
4. Uncommon extent involvement of sarcoidosis in 18F-FDG PET/CT.
Küçük NO; Ozkan E; Aras G
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2151. PubMed ID: 17874096
[No Abstract] [Full Text] [Related]
5. [Active cardiac sarcoidosis: Diagnosis and adjustment of therapy with FDG PET/CT].
Philippe L; Casset-Senon D; Lorette G; Diot P; Cosnay P
Presse Med; 2015 Jun; 44(6 Pt 1):690-2. PubMed ID: 25534464
[No Abstract] [Full Text] [Related]
6. 18F-fluoro-deoxyglucose PET for monitoring treatment in sarcoidosis.
Mortensen J; Loft A; Baslund B
Clin Respir J; 2007 Dec; 1(2):124-6. PubMed ID: 20298294
[No Abstract] [Full Text] [Related]
7. Diagnosis of unknown sarcoidosis associated to erythema nodosum with 18F-FDG PET/CT.
Rampin L; Musto A; Marzola MC; Tadayyon S; Ferretti A; Chondrogiannis S; Grassetto G; Rubello D
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):190-2. PubMed ID: 23522858
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT.
Matthews R; Bench T; Meng H; Franceschi D; Relan N; Brown DL
J Nucl Cardiol; 2012 Aug; 19(4):807-10. PubMed ID: 22466988
[No Abstract] [Full Text] [Related]
9. Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT.
Zivin S; David O; Lu Y
Intern Med; 2014; 53(21):2555-6. PubMed ID: 25366024
[No Abstract] [Full Text] [Related]
10. Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis.
Tannen BL; Ghesani NV; Frohman L; Eichler JD; Maldjian PD; Chu DS
Ocul Immunol Inflamm; 2008; 16(1):25-7. PubMed ID: 18379938
[TBL] [Abstract][Full Text] [Related]
11. Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis.
Shulman JP; Latkany P; Chin KJ; Finger PT
Ocul Immunol Inflamm; 2009; 17(2):95-100. PubMed ID: 19412870
[TBL] [Abstract][Full Text] [Related]
12. Interesting image. F-18 fluorodeoxyglocose positron emission tomography/computed tomography in the diagnosis of chronic myopathic sarcoidosis.
Loe MJ; Subramaniam RM; Kalra S; Tiegs RD; Mullan BP; Utz JP
Clin Nucl Med; 2010 Jan; 35(1):22-3. PubMed ID: 20026967
[No Abstract] [Full Text] [Related]
13. Extra-pulmonary manifestations of sarcoidosis.
Vardhanabhuti V; Venkatanarasimha N; Bhatnagar G; Maviki M; Iyengar S; Adams WM; Suresh P
Clin Radiol; 2012 Mar; 67(3):263-76. PubMed ID: 22094184
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic challenge of mediastinal sarcoidosis accompanying esophageal cancer.
Schauer M; Theisen J
World J Surg Oncol; 2010 Mar; 8():15. PubMed ID: 20226059
[TBL] [Abstract][Full Text] [Related]
16. Sarcoidosis and lymphoma: case series and literature review.
Maayan H; Ashkenazi Y; Nagler A; Izbicki G
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):146-52. PubMed ID: 22117506
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
18. Role of [(18)F]fluorodeoxyglucose positron emission tomography-computed tomography for diagnosis and treatment of sarcoidosis in an HIV-2-infected patient.
Nicolini LA; Taramasso L; Ferrarazzo G; Fiz F; Sambuceti G; Viscoli C; Di Biagio A
AIDS Res Hum Retroviruses; 2015 Sep; 31(9):868-9. PubMed ID: 25870097
[No Abstract] [Full Text] [Related]
19. F-18 FDG PET/CT for detecting bone and bone marrow involvement in sarcoidosis patients.
Mostard RL; Prompers L; Weijers RE; van Kroonenburgh MJ; Wijnen PA; Geusens PP; Drent M
Clin Nucl Med; 2012 Jan; 37(1):21-5. PubMed ID: 22157023
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary sarcoidosis: a clinical update.
Hu MK; Mathur A; Dempsey OJ
J R Coll Physicians Edinb; 2020 Sep; 50(3):322-329. PubMed ID: 32936114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
